Synopsys (NASDAQ:SNPS | SNPS Price Prediction) below $500 looks priced for an AI story the business does not fully support. The AI multiple attached to this stock fits worse than the valuation implies, and cleaner AI exposure exists elsewhere in the semi stack.
Synopsys is the larger of the two electronic design automation giants. It sells the software chip designers use to lay out, simulate, and verify silicon. It also licenses interface IP blocks like PCIe, USB, and DDR. Last July it closed its acquisition of Ansys, the multiphysics simulation company, and rebranded as a silicon-to-systems platform.
The stock has round-tripped. After closing above $620 last summer, it slid through a Q3 FY2025 miss and recovered with a strong Q1 FY2026 report, but still sits 3% below where it traded a year ago.
What the bulls see in a sub-$500 entry
Q1 FY2026 revenue came in at $2.41 billion, up 66% year over year, with non-GAAP EPS of $3.77 against a $3.56 consensus. Backlog stands at $11.3 billion, and Synopsys has beaten estimates in 11 of the last 12 quarters.
Ansys adds roughly $2.9 billion at the midpoint of FY2026 revenue, with management targeting $400 million each in revenue and cost synergies. CEO Sassine Ghazi told investors “AI isn’t disrupting our business; it’s amplifying our strategic advantage” during the Q1 FY2026 earnings call.
Activist Elliott Investment Management holds a stake, and the recent average consensus target of $541 implies just 9% upside from current levels.
Why the AI premium does not fit this business
Synopsys is not capturing the AI cycle the way the multiple suggests. Its IP catalog leans toward interface IP plus automotive and consumer-grade silicon. The marquee AI designs at NVIDIA, Google, and Amazon use heavy doses of custom and proprietary IP that bypasses the Synopsys catalog. The smartphone and automotive end markets where Synopsys IP attaches most aggressively have been soft.
Design IP revenue was $407 million in Q1, down roughly 6% year over year, and Ghazi flagged 2026 as a transitional year for the segment. Long-term debt sits at $13.46 billion after Ansys, with another $200 million to $250 million in restructuring charges planned for FY2026. China, historically about 10% of revenue, remains capped by entity-list and export-control restrictions.
The case for waiting
The business itself is healthy. Operating cash flow swung to $857 million in Q1, free cash flow guidance for the year runs near $1.9 billion, and management nudged FY non-GAAP EPS guidance to $14.38 to $14.46. A patient investor could wait for the May 27 report to confirm whether IP inflects back to growth, whether Ansys synergies arrive on plan, and whether China commentary stabilizes.
Trailing P/E sits near 77x, forward P/E near 34x, and PEG at 1.8. Year to date SNPS is up 3% while the S&P 500 has returned 8.2%. That is a wide gap for a stock the market keeps labeling an AI beneficiary.
Even below $500, the multiple asks too much
The bull case rests on SNPS as an AI tollbooth. The segment data tells a different story. The customers minting AI revenue at hyperscale are building custom silicon with proprietary IP that bypasses the Synopsys catalog, and the IP segment actually shrank year over year while consensus expects acceleration.
Strip Ansys out of the 65% YoY headline and the underlying Synopsys business grows in the mid-single to low-double digits. That deserves a steady software multiple. At $94 billion of market cap, the market is paying for an AI compounder it has not actually proven to be.
What invalidates this view is a clean May 27 report showing IP revenue inflecting back to growth, durable design starts outside AI hyperscale, and Ansys cross-sell revenue arriving ahead of plan. Absent that, the next leg likely compresses the multiple. Investors who own SNPS to play the AI build-out can find cheaper, more direct exposure elsewhere in the semi stack.
Synopsys is a fine company at a price that asks too much for an AI story it cannot fully tell.
Top Gaining Stocks
Top Losing Stocks